CD30 contains two binding sites with different specificities for members of the tumor necrosis factor receptor-associated factor family of signal transducing proteins

被引:148
作者
Gedrich, RW
Gilfillan, MC
Duckett, CS
VanDongen, JL
Thompson, CB
机构
[1] UNIV CHICAGO,GWEN KNAPP CTR LUPUS & IMMUNOL RES,DEPT MED,CHICAGO,IL 60637
[2] UNIV CHICAGO,COMM IMMUNOL,CHICAGO,IL 60637
[3] UNIV CHICAGO,HOWARD HUGHES MED INST,DEPT MOLEC GENET & CELL BIOL,CHICAGO,IL 60637
关键词
D O I
10.1074/jbc.271.22.12852
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
CD30 is a member of the tumor necrosis factor (TNF) receptor family of proteins. CD30 can regulate proliferation of lymphocytes and may also play an important role in human immunodeficiency virus replication, However, little is known about CD30 signal transduction. We performed a yeast two-hybrid library screen with the cytoplasmic domain of CD30 and isolated multiple independent cDNAs encoding human tumor necrosis factor receptor-associated factor (TRAF) 1, TRAF2, and GRAF1 (TRAF3). The ability of TRAF1, TRAF2, and CRAF1 to associate with CD30 was confirmed using an in vitro coprecipitation assay, further demonstrating that the interaction was specific and direct. The TRAF-binding domain of CD30 was mapped to the COOH-terminal 36 amino acid residues, which contained two independent binding sites. CRAF1 bound only a single site, which contained the sequence PEQET, whereas TRAF1 and TRAF2 were capable of binding to either the PEQET site or an additional downstream domain. These data indicate that the TRSF protein binding pattern of CD30 differs from other TNF receptor family members and suggest that signaling specificity through TNF receptor family proteins may be achieved through differences in their abilities to bind TRAF proteins.
引用
收藏
页码:12852 / 12858
页数:7
相关论文
共 52 条
[1]  
ANDREESEN R, 1984, BLOOD, V63, P1299
[2]   THE CD40 ANTIGEN AND ITS LIGAND [J].
BANCHEREAU, J ;
BAZAN, F ;
BLANCHARD, D ;
BRIERE, F ;
GALIZZI, JP ;
VANKOOTEN, C ;
LIU, YJ ;
ROUSSET, F ;
SAELAND, S .
ANNUAL REVIEW OF IMMUNOLOGY, 1994, 12 :881-922
[3]  
BERBERICH I, 1994, J IMMUNOL, V153, P4357
[4]  
BISWAS P, 1995, IMMUNITY, V2, P587
[5]   INVOLVEMENT OF CRAF1, A RELATIVE OF TRAF, IN CD40 SIGNALING [J].
CHENG, GH ;
CLEARY, AM ;
YE, ZS ;
HONG, DI ;
LEDERMAN, S ;
BALTIMORE, D .
SCIENCE, 1995, 267 (5203) :1494-1498
[6]   FADD, A NOVEL DEATH DOMAIN-CONTAINING PROTEIN, INTERACTS WITH THE DEATH DOMAIN OF FAS AND INITIATES APOPTOSIS [J].
CHINNAIYAN, AM ;
OROURKE, K ;
TEWARI, M ;
DIXIT, VM .
CELL, 1995, 81 (04) :505-512
[7]   THE ROLE OF BCL-X(L) IN CD40-MEDIATED RESCUE FROM ANTI-MU-INDUCED APOPTOSIS IN WEHI-231 B-LYMPHOMA-CELLS [J].
CHOI, MSK ;
BOISE, LH ;
GOTTSCHALK, AR ;
QUINTANS, J ;
THOMPSON, CB ;
KLAUS, GGB .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1995, 25 (05) :1352-1357
[8]   CONTENDERS IN FASL/TNF DEATH SIGNALING [J].
CLEVELAND, JL ;
IHLE, JN .
CELL, 1995, 81 (04) :479-482
[9]   CD30, TH2 CYTOKINES AND HIV-INFECTION - A COMPLEX AND FASCINATING LINK [J].
DELPRETE, G ;
MAGGI, E ;
PIZZOLO, G ;
ROMAGNANI, S .
IMMUNOLOGY TODAY, 1995, 16 (02) :76-80
[10]   CD30-MEDIATED SIGNALING PROMOTES THE DEVELOPMENT OF HUMAN T-HELPER TYPE 2-LIKE T-CELLS [J].
DELPRETE, G ;
DECARLI, M ;
DELIOS, MM ;
DANIEL, KC ;
ALMERIGOGNA, F ;
ALDERSON, M ;
SMITH, CA ;
THOMAS, E ;
ROMAGNANI, S .
JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 182 (06) :1655-1661